Comparison of the Effectiveness of Brexpiprazole With That of Risperidone
Researchers are comparing brexpiprazole and risperidone to find out how the approaches affect quality of life in adults with schizophrenia.
Understand this study
What is this study about?
Researchers are comparing brexpiprazole and risperidone to find out how the approaches affect quality of life in adults with schizophrenia.
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- H. Lundbeck A/S
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02758067
- Official title
Show the full official title
Interventional, Randomised, Double-blind, Parallel-group, Active-comparator, Flexible-dose Study to Compare the Effectiveness of Brexpiprazole to That of Risperidone in Adult Patients With Schizophrenia
Recruitment & locations
Locations not listed
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing brexpiprazole and risperidone to find out how the approaches affect quality of life in adults with schizophrenia.
Who is behind this study?
The study sponsor is H. Lundbeck A/S.
Does this study involve medication?
Yes. The study involves medication, including brexpiprazole and risperidone.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as withdrawn.
